COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY
Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11
Abstract
Generic Rosuvastatin formulation has been developed which is comparatively cost-effective as well as bio-similar in efficacy in compared with the Brand drug Crestor (Rosuvastatin). Research shows that overpriced medicines causes huge national burden and health care expenses has gone out of control. A Study results shows that millions of adults patients skip over medications to buy due to their high cost (Robin A. Cohen, Maria A. Villarroel, NCSH Researchers. 2013).[1] Research also found that patients are used to save money on drugs costs and they asked doctors for lower-cost medications, buying prescription drugs from other countries and using alternative therapies. So, high drugs costs problems can be handled by development of cost-effective generic drugs with same therapeutic efficacy or bio-similar to brand name drugs. According to US. FDA - a generic medicine give the identical clinical benefit and works in the same way like other brand-name version drugs. This standard applies to all FDA-approved generic medicines in safety, dosage form, strength, quality, route of administration, and intended use”(US FDA 2017).[2] So, with the main focusing of cost-defective formulation development, we have tried to evaluate the overall quality of developed drugs from the points of - dosage form, therapeutic efficacy, strength, safety, route of administration, performance quality, characteristics and intended use. We have conducted an In-Vitro Bio-Equivalence Study to establish the bio-similarity of Generic Rosuvastatin and we have achieved similar results like Brand name Rosuvastatin- Crestor. New developed Generic Rosuvastatin tablets found therapeutically bio-equivalent as the Brand name innovator and more cost-effective than brand drug.
Authors and Affiliations
Farzana Hasin
Keywords
Related Articles
- EP ID EP674247
- DOI -
- Views 252
- Downloads 0
IMPROVED GLUCOSE TOLERANCE WITH A POLYHERBAL FORMULATION OF COLOCASIA ESCULENTA TUBERS AND ALLIUM SATIVUM CLOVES
Background: Colocasia esculenta and Allium sativum are cultivated in Bangladesh, respectively, for consumption of tubers as vegetable and use of cloves as spice. Both plant parts have previously been reported to have ant...
PHYSICAL GROWTH PATTERNS IN TRANSFUSION-DEPENDENT THALASSEMIC CHILDREN AT WASIT CITY
Objectives: Aim of Study: The main aim of this study is to determine the effects of age, type of chelation therapy, ferritin level and hemoglobin level on the physical growth of transfusion dependent thalassemia children...
TREATMENT OF PSYCHOSIS DISRORDER
Psychosis is refers to an abnormal condition of mind in which person loss his contact with reality and the person suffures from psychosis is called as psychotic. Psychosis makes people confuse or misintepret what is goin...
FOOD TABOOS AND SUGGESTIONS AMONG MADURESE PREGNANT WOMEN
The study revealed that food taboos and misconceptions pregnancy exist, one-half of the women in the study area were obligated to avoid specific food items due to cultural and traditional views. Less educated women were,...
DOCKING, SYNTHESIS AND CYTOTOXIC TEST ON HUMAN BREAST CANCER CELL LINE T47D OF N- (PHENYLCARBAMOTHIOYL)-BENZAMIDE
Introduction: New breast anticancer compound N- (phenylcarbamothioyl)-benzamide have been synthesized, initiated with molecular modeling in silico which is docking between test compounds with SIRT-1 receptor PDB code: 4I...